Advances in the Effects of Antiphospholipid Syndrome on Female Infertility and Outcomes of Assisted Reproductive Technologies

LANG Man-ning; LI Wei-hong

doi:10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2023.0406

您当前的位置：

首页 >

文章列表页 >

Advances in the Effects of Antiphospholipid Syndrome on Female Infertility and Outcomes of Assisted Reproductive Technologies

Review | 更新时间：2024-02-19

- Advances in the Effects of Antiphospholipid Syndrome on Female Infertility and Outcomes of Assisted Reproductive Technologies
- Journal of Sun Yat-sen University(Medical Sciences) Vol. 44, Issue 4, Pages: 582-586(2023)
- 作者机构：
  
  重庆医科大学附属第一医院生殖医学中心，重庆 400016
- 作者简介：
  
  LI Wei-hong； E-mail： liweihong1211@163.com
- 基金信息：
- DOI：10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2023.0406
  CLC： R71
- Published：20 July 2023，
  
  Received：19 March 2023，
扫描看全文
郎曼凝,李维宏.抗磷脂综合征对女性不孕及体外受精-胚胎移植助孕结局的研究进展[J].中山大学学报（医学科学版）,2023,44(04):582-586.

LANG Man-ning,LI Wei-hong.Advances in the Effects of Antiphospholipid Syndrome on Female Infertility and Outcomes of Assisted Reproductive Technologies[J].Journal of Sun Yat-sen University(Medical Sciences),2023,44(04):582-586.
郎曼凝,李维宏.抗磷脂综合征对女性不孕及体外受精-胚胎移植助孕结局的研究进展[J].中山大学学报（医学科学版）,2023,44(04):582-586. DOI： 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2023.0406.

LANG Man-ning,LI Wei-hong.Advances in the Effects of Antiphospholipid Syndrome on Female Infertility and Outcomes of Assisted Reproductive Technologies[J].Journal of Sun Yat-sen University(Medical Sciences),2023,44(04):582-586. DOI： 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2023.0406.

摘要

抗磷脂综合征（APS）是一种与抗磷脂抗体持续存在有关的自身免疫性疾病，其主要特征为血栓形成和妊娠相关疾病的发生。APS可能通过影响卵巢功能、子宫蜕膜化等方式对女性的生殖功能造成不利的影响，并可能在体外受精-胚胎移植（IVF-ET）治疗中引起胚胎种植失败、胚胎种植后的妊娠丢失。常规在不孕人群IVF-ET前进行APS的筛查、治疗尚存在争议，应对患者的风险进行个体化评估，采取相应的管理措施，提高患者的助孕成功率，降低妊娠期母胎风险。本文综述了APS对不孕及IVF助孕结局的影响与人群的管理，为临床诊治提供新思路。

Abstract

Antiphospholipid syndrome （APS） is an autoimmune disease characterized by the persistent presence of antiphospholipid antibodies， which are associated with thrombosis and pregnancy-related complications. APS may have adverse effects on female reproductive function by affecting ovarian function， endometrialization， and other mechanisms， and may lead to embryo implantation failure and pregnancy loss during in vitro fertilization and embryo transfer （IVF-ET） treatments. The routine screening and management of APS before IVF-ET in infertile populations remains controversial and requires individualized risk assessment and appropriate management measures to improve the success rate of assisted reproductive technologies （ART） and reduce maternal and fetal risks during pregnancy. This review summarizes the effects of APS on female infertility and outcomes of ART， as well as the management of the population affected by APS， providing new insights for clinical diagnosis and treatment.

关键词

抗磷脂综合征不孕体外受精-胚胎移植

Keywords

antiphospholipid syndromeinfertilityin vitro fertilization and embryo transfer

references

Garcia D， Erkan D. Diagnosis and Management of the Antiphospholipid Syndrome［J］. N Engl J Med， 2018， 378（21）： 2010-2021.

中华医学会围产医学分会. 产科抗磷脂综合征诊断与处理专家共识［J］. 中华围产医学杂志， 2020，（8）： 517-522.

Chinese Society of Perinatal Medicine. Expert consensus on the diagnosis and treatment of obstetric antiphospholipid syndrome［J］. Chin J Perinat Med， 2020，（8）： 517-522.

Galarza-Maldonado C， Kourilovitch MR， Pérez-Fernández OM， et al. Obstetric antiphospholipid syndrome［J］. Autoimmun Rev， 2012， 11（4）： 288-295.

Khizroeva J， Makatsariya A， Bitsadze V， et al. In vitro fertilization outcomes in women with antiphospholipid antibodies circulation［J］. The Journal of Maternal-Fetal & Neonatal Medicine， 2020， 33（12）： 1988-1993.

Chighizola CB， De Jesus GR， Branch DW. The hidden world of anti-phospholipid antibodies and female infertility： a literature appraisal［J］. Autoimmun Rev， 2016， 15（6）： 493-500.

中华医学会风湿病学分会. 抗磷脂综合征诊断和治疗指南［J］. 中华风湿病学杂志， 2011（6）： 407-410.

Chinese Rheumatology Association. Diagnosis and treatment guidelines for antiphospholipid syndrome［J］. Chin J Rheumatol， 2011（6）： 407-410.

Miyakis S， Lockshin MD， Atsumi T， et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome （APS）［J］. Journal of Thrombosis and Haemostasis， 2006， 4（2）： 295-306.

张嫱，徐影，代晓微，等. 肠道菌群与不孕症相关疾病的研究进展［J］. 新医学， 2023， 54（2）： 115-119.

Zhang Q， Xu Y， Dai XW， et al. Research progress on gut microbiota and infertility-related diseases［J］. J New Med， 2023， 54（2）： 115-119.

Chighizola CB， Raimondo MG， Meroni PL. Does APS Impact Women's Fertility？［J］. Curr Rheumatol Rep， 2017， 19（6）： 33.

Del Porto F， Ferrero S， Cifani N， et al. Antiphospholipid antibodies and idiopathic infertility［J］. Lupus， 2022， 31（3）： 347-353.

Francis J， Rai R， Sebire NJ， et al. Impaired expression of endometrial differentiation markers and complement regulatory proteins in patients with recurrent pregnancy loss associated with antiphospholipid syndrome［J］. Mol Hum Reprod， 2006， 12（7）： 435-442.

Chaouat G. Inflammation， NK cells and implantation： friend and foe （the good， the bad and the ugly？）： replacing placental viviparity in an evolutionary perspective［J］. J Reprod Immunol， 2013， 97（1）： 2-13.

Vega M， Barad DH， Yu Y， et al. Anti-mullerian hormone levels decline with the presence of antiphospholipid antibodies［J］. Am J Reprod Immunol， 2016， 76（4）： 333-337.

Yamakami L， Serafini P， De Araujo D， et al. Ovarian reserve in women with primary antiphospholipid syndrome［J］. Lupus， 2014， 23（9）： 862-867.

Zhong YP， Ying Y， Wu HT， et al. Impact of anticardiolipin antibody on the outcome of in vitro fertilization and embryo transfer［J］. Am J Reprod Immunol， 2011， 66（6）： 504-509.

Wu L， Fang X， Lu F， et al. Anticardiolipin and/or anti-β2-glycoprotein-I antibodies are associated with adverse IVF outcomes［J］. Front Immunol， 2022， 13： 986893.

Mahdian S， Pirjani R， Favaedi R， et al. Platelet-activating factor and antiphospholipid antibodies in recurrent implantation failure［J］. J Reprod Immunol， 2021， 143： 103251.

Jarne-Borràs M， Miró-Mur F， Anunciación-Llunell A， et al. Antiphospholipid antibodies in women with recurrent embryo implantation failure： A systematic review and meta-analysis［J］. Autoimmun Rev， 2022， 21（6）： 103101.

Tan X， Ding J， Pu D， et al. Anti-phospholipid antibody may reduce endometrial receptivity during the window of embryo implantation［J］. J Gynecol Obstet Hum Reprod， 2021， 50（6）： 101912.

Proulle V， Furie RA， Merrill-Skoloff G， et al. Platelets are required for enhanced activation of the endothelium and fibrinogen in a mouse thrombosis model of APS［J］. Blood， 2014， 124（4）： 611-622.

Agostinis C， Biffi S， Garrovo C， et al. In vivo distribution of β2 glycoprotein I under various pathophysiologic conditions［J］. Blood， 2011， 118（15）： 4231-4238.

Song Y， Wang HY， Qiao J， et al. Antiphospholipid antibody titers and clinical outcomes in patients with recurrent miscarriage and antiphospholipid antibody syndrome： a prospective study［J］. Chin Med J （Engl）， 2017， 130（3）： 267-272.

崔佳，赵培，马倩，等. 狼疮抗凝物、抗β2糖蛋白1抗体及抗心磷脂抗体对妊娠不良事件的影响［J］. 河北医药， 2020， 42（24）： 3750-3753.

Cui J， Zhao P， Ma Q， et al. Effects of anticoagulant， anti-β2-glycoprotein 1 antibody， and anti-cardiolipin antibody in patients with lupus on adverse pregnancy outcomes［J］. Hebei Med J， 2020， 42（24）： 3750-3753.

崔金晖，李萍，李玲，等. 系统性红斑狼疮合并妊娠的回顾性分析［J］. 中山大学学报（医学科学版）， 2020， 41（03）： 473-478.

Cui JH， Li P， Li L， MENG Zhao-ran， FAN Jian-hui. Retrospective Clinical Analysis of Pregnant Patients With Systemic Lupus Erythematosus ［J］. J Sun Yat-sen Univ（Med Sci）， 2020， 41（3）： 473-478.

Alijotas-Reig J， Esteve-Valverde E， Ferrer-Oliveras R， et al. The European Registry on Obstetric Antiphospholipid Syndrome （EUROAPS）： a survey of 1000 consecutive cases［J］. Autoimmun Rev， 2019， 18（4）： 406-414.

Gao R， Zeng R， Qing P， et al. Antiphospholipid antibodies and pregnancy outcome of assisted reproductive treatment： a systematic review and meta-analysis［J］. Am J Reprod Immunol， 2021， 86（4）： e13470.

Liu Z， Sun S， Xu H， et al. Prognostic analysis of antibody typing and treatment for antiphospholipid syndrome-related recurrent spontaneous abortion［J］. Int J Gynaecol Obstet， 2022， 156（1）： 107-111.

Tektonidou MG， Andreoli L， Limper M， et al. EULAR recommendations for the management of antiphospholipid syndrome in adults［J］. Ann Rheum Dis， 2019， 78（10）： 1296-1304.

Rodrigues VO， Soligo A， Pannain GD. Antiphospholipid antibody syndrome and Infertility［J］. Rev Bras Ginecol Obstet， 2019， 41（10）： 621-627.

Gris JC， Bouvier S， Nouvellon E， et al. Antiphospholid antibodies and the risk of pregnancy complications［J］. Thromb Res， 2017， 151 Suppl 1： S34-s37.

Ulcova-Gallova Z， Krauz V， Novakova P， et al. Anti-phospholipid antibodies against phosphatidylinositol， and phosphatidylserine are more significant in reproductive failure than antibodies against cardiolipin only［J］. Am J Reprod Immunol， 2005， 54（2）： 112-117.

Liu T， Gu J， Wan L， et al. "Non-criteria" antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort［J］. Arthritis Res Ther， 2020， 22（1）： 33.

Kim MY， Buyon JP， Guerra MM， et al. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies： results of the PROMISSE study［J］. Am J Obstet Gynecol， 2016， 214（1）： 108.e101-108.e114.

Tong M， Kayani T， Jones DM， et al. Antiphospholipid antibodies increase endometrial stromal cell decidualization， senescence， and inflammation via toll-like receptor 4， reactive oxygen species， and p38 MAPK signaling［J］. Arthritis Rheumatol， 2022， 74（6）： 1001-1012.

Ying Y， Zhong YP， Zhou CQ， et al. A retrospective study on IVF outcome in patients with anticardiolipin antibody： effects of methylprednisolone plus low-dose aspirin adjuvant treatment［J］. J Reprod Immunol， 2012， 94（2）： 196-201.

Vanni VS， De Lorenzo R， Privitera L， et al. Safety of fertility treatments in women with systemic autoimmune diseases （SADs）［J］. Expert Opinion on Drug Safety， 2019， 18（9）： 841-852.

Giner V， Oltra MR， Esteban MJ， et al. Catastrophic antiphospholipid syndrome related to severe ovarian hyperstimulation［J］. Clin Rheumatol， 2007， 26（6）： 991-993.

赵久良，沈海丽，柴克霞，等. 抗磷脂综合征诊疗规范［J］. 中华内科杂志， 2022，（9）： 1000-1007.

Zhao JL， Shen HL， Chai KX， et al. Diagnosis and treatment guidelines for antiphospholipid syndrome［J］. Chin J Intern Med， 2022，（9）： 1000-1007.

Hamulyák EN， Scheres LJ， Marijnen MC， et al. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss［J］. Cochrane Database Syst Rev， 2020， 5（5）： Cd012852.

Alijotas-Reig J， Esteve-Valverde E， Llurba E， et al. Treatment of refractory poor aPL-related obstetric outcomes with TNF-alpha blockers： maternal-fetal outcomes in a series of 18 cases［J］. Semin Arthritis Rheum， 2019， 49（2）： 314-318.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Enhancement of Diagnosis of Chronic Endometritis by CD138 and Assessment of Risk Factors Associated with Chronic Endometritis on Infertility

Related Author

No data

Related Institution

No data

Postal code：510080
Tel：020-87331643，87330827 Email：xbmed@mail.sysu.edu.cn
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰